Estrella Immunopharma Inc
ESLA0.820USD
-0.035-4.08%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
0.820USD+0.820After-hours (ET)
29.66MMarket Cap
LossP/E TTM
Estrella Immunopharma Inc
0.820
-0.035-4.08%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-69.33%-465.98K
-574.10%-291.51K
-4914.13%-4.23M
-10313.48%-11.27M
74.99%-275.19K
---43.24K
---84.45K
---108.20K
---1.10M
Net income from continuing operations
-12.50%-2.10M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
---2.73M
---2.74M
---2.76M
---2.89M
Other non-cash items
----
----
----
-99.99%1.00
----
----
--5.49K
--8.98K
----
Change in working capital
269.21%1.48M
41.52%3.66M
-247.72%-3.77M
-503.91%-10.25M
-76.19%400.65K
--2.59M
--2.55M
--2.54M
--1.68M
-Change in prepaid expenses
--201.07K
10539.26%3.62M
-6909.72%-3.50M
---262.48K
-100.00%0.00
--34.00K
---50.00K
--0.00
--833.33K
-Change in payables and accrued expense
-121.26%-83.92K
-36.49%42.41K
-581.06%-181.17K
-1373.93%-705.97K
497.68%394.77K
--66.78K
--37.66K
---47.90K
--66.05K
Cash from non-recurring investing activities
Cash from operating activities
-69.33%-465.98K
-574.10%-291.51K
-4914.13%-4.23M
-10313.48%-11.27M
74.99%-275.19K
---43.24K
---84.45K
---108.20K
---1.10M
Investing cash flow
Net cash flow from other investing activities
100.00%0.00
100.00%0.00
100.00%0.00
--5.07M
---112.30K
---136.53K
---136.53K
--0.00
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
100.00%0.00
100.00%0.00
100.00%0.00
--5.07M
---112.30K
---136.53K
---136.53K
--0.00
--0.00
Financing cash flow
Cash flow from continuous financing activities
-100.15%-29.46K
---270.35K
---84.09K
---6.90M
--20.05M
----
----
--0.00
--0.00
Net cash flow from debt Issuance/repayment
----
--0.00
--0.00
--0.00
--300.00K
----
----
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
---29.46K
---270.35K
---84.09K
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
--0.00
--0.00
--0.00
--9.02M
----
----
--0.00
--0.00
Net cash flow from other financing activities
-100.00%0.00
--0.00
--0.00
---6.90M
--10.73M
----
----
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.15%-29.46K
---270.35K
---84.09K
---6.90M
--20.05M
----
----
--0.00
--0.00
Net cash flow
Beginning cash balance
-63.01%916.92K
77.79%4.73M
214.11%9.05M
640.87%22.14M
-39.36%2.48M
--2.66M
--2.88M
--2.99M
--4.09M
Current period cash flow changes
-102.52%-495.44K
-212.53%-561.86K
-1854.29%-4.32M
-12000.24%-13.09M
1886.80%19.66M
---179.78K
---220.99K
---108.20K
---1.10M
Ending cash balance
-98.10%421.47K
68.02%4.17M
77.79%4.73M
214.11%9.05M
640.87%22.14M
--2.48M
--2.66M
--2.88M
--2.99M
Free cash flow
-705.79%-2.22M
-574.10%-291.51K
-4914.13%-4.23M
-10313.48%-11.27M
74.99%-275.19K
---43.24K
---84.45K
---108.20K
---1.10M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
